{"transactions":[{"id":9953,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-11T23:36:55.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":446,"price":331.11,"value":147675.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30016,"source":{"system":"sec-edgar","filing":"0000318154-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000083/form4.xml","form_type":"4"}},{"id":10039,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":21773,"price":329.59,"value":7176163.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":21773,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":21773},"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":10038,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":407,"price":329.59,"value":134143.13,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,332 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30462,"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":10037,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":30869,"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":14334,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-02-10T23:39:06.000Z","date":"2026-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":953,"price":384.32,"value":366256.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,205 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":27378,"source":{"system":"sec-edgar","filing":"0000318154-26-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000006/form4.xml","form_type":"4"}},{"id":14333,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-02-10T23:39:06.000Z","date":"2026-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2151,"price":384.32,"value":826672.32,"ownership":{"direct":true},"balance_after":28331,"source":{"system":"sec-edgar","filing":"0000318154-26-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000006/form4.xml","form_type":"4"}},{"id":24238,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2025-05-09T00:49:53.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":22944,"price":270.44,"value":6204975.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and are exercisable in four equal annual installments of 25% each commencing on 5/6/2026."}],"balance_after":22944,"derivative":{"exercise_price":270.44,"exercise_date":"2026-05-06","expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":22944},"source":{"system":"sec-edgar","filing":"0001127602-25-013778","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013778/form4.xml","form_type":"4"}},{"id":24237,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Common Stock","published_at":"2025-05-09T00:49:53.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":3549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 948 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":29753,"source":{"system":"sec-edgar","filing":"0001127602-25-013778","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013778/form4.xml","form_type":"4"}},{"id":41082,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2024-05-09T22:59:37.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":18603,"price":300.3,"value":5586480.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."}],"balance_after":18603,"derivative":{"exercise_price":300.3,"exercise_date":"2026-05-07","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":18603},"source":{"system":"sec-edgar","filing":"0001127602-24-014850","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014850/form4.xml","form_type":"4"}},{"id":41081,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Common Stock","published_at":"2024-05-09T22:59:37.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":2863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028,\nrespectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan: 8,587 RSUs which will vest in installments of 2,833 on 2/9/2026, 2,834 on 2/9/2027, and 2,920 on 2/9/2028; 13,806 RSUs which will vest in installments of 4,555 on 2/9/2026, 4,556 on 2/9/2027, and 4,695 on 2/9/2028; and 2,863 RSUs which will vest in installments of 944 on 5/7/2026, 945 on 5/7/2027, and 974 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 182 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting\nperson's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":25438,"source":{"system":"sec-edgar","filing":"0001127602-24-014850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014850/form4.xml","form_type":"4"}},{"id":46645,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Common Stock","published_at":"2024-02-13T00:50:46.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":13806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 2/9/2026, 2/9/2027 and 2/9/2028,\nrespectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan: 8,587 RSUs which will vest in installments of 2,833 on 2/9/2026, 2,834 on 2/9/2027, and 2,920 on 2/9/2028; and 13,806 RSUs which will vest in installments of 4,555 on 2/9/2026, 4,556 on 2/9/2027, and 4,695 on 2/9/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":22393,"source":{"system":"sec-edgar","filing":"0001127602-24-004620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224004620/form4.xml","form_type":"4"}},{"id":46644,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, R&D, & Chief Sci. Officer"}}],"security":"Common Stock","published_at":"2024-02-13T00:50:46.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":8587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 2/9/2026, 2/9/2027 and 2/9/2028,\nrespectively."}],"balance_after":8587,"source":{"system":"sec-edgar","filing":"0001127602-24-004620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224004620/form4.xml","form_type":"4"}}]}